In addition, the above binding induces TLR4-dependent signaling in platelets, leading to their hyper-reactivity, aggregation, and an increased risk of thrombosis in patients with MASLD [77] as discussed further in this paper. This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatotic liver disease.